Dupixent CTCL Lawyer

When a Cancer Diagnosis Follows Medication Use, You Need a Dupixent Lymphoma Attorney in Your Corner

A cancer diagnosis changes everything. When that diagnosis follows months or years of treatment with a drug you were told was safe, a medication prescribed to manage your eczema, asthma, or another chronic inflammatory condition, the questions come fast. Why did this happen? Was this preventable? Is anyone responsible? Lawsuits are now being filed against Dupixent manufacturers Sanofi and Regeneron, alleging that both companies knew about the connection between Dupixent and cutaneous T-cell lymphoma but failed to warn patients and their doctors. If you or a loved one developed CTCL after using Dupixent, a Dupixent CTCL lawyer at Spotlight Justice can give you straightforward answers about your legal options and fight for the accountability you deserve.

Founding and managing attorney Dena Young personally reviews each Dupixent cases we take on. With 15 years of legal experience and a deep background in mass tort litigation and other complex injury matters, Dena is committed to ensuring you receive direct, consistent communication and always know where your case stands. Contact our firm today for a free evaluation of your potential Dupixent case.

Your Path to Filing a Dupixent CTCL Lawsuit

Dupixent CTCL litigation is open to patients who used the medication dupilumab, whether for an FDA-approved indication or an off-label use, and who were diagnosed with cutaneous T-cell lymphoma or a qualifying subtype during or after treatment.

If you are unsure whether your specific diagnosis qualifies, that uncertainty is exactly the reason to reach out. Attorney Dena Young will review your situation personally, at no cost, and with no obligation to proceed.

You may have grounds for a Dupixent lymphoma lawsuit if:

• You were prescribed and used Dupixent (dupilumab) for any condition, whether FDA-approved or off-label
• You were diagnosed with CTCL or one of its subtypes during or after your use of Dupixent
• You have not already filed a lawsuit related to your Dupixent CTCL diagnosis

If you lost a loved one who was diagnosed with CTCL following Dupixent use, you may also be able to pursue a wrongful death claim on their behalf.

Acting promptly matters. Every state has a statute of limitations, a legal deadline that governs how long you have to file a personal injury or wrongful death claim. Missing that window can mean losing your right to seek compensation entirely. A free consultation with Attorney Dena Young, a Dupixent CTCL lawyer, costs you nothing, but it could protect everything.

CTCL Risk With Use of Dupixent: Emerging Evidence of an Increased Lymphoma Risk Linked to Dupixent Use

Multiple studies have reported a significantly increased risk of CTCL in patients treated with Dupixent, raising serious questions about the drug’s role in the development or progression of this cancer.

The claims being made in Dupixent litigation are grounded in peer-reviewed research and mounting safety data that raise serious questions about what Sanofi and Regeneron knew, and how long they knew it before patients were given any warning.

Understanding what Dupixent is, how it works, and what the science shows about its connection to cutaneous T-cell lymphoma can help you put your own experience into context.

What Dupixent Is and Who It Affects

Dupixent (dupilumab) is a prescription biologic medication approved by the FDA to treat a number of conditions:

• Moderate to severe eczema (atopic dermatitis)
• Asthma
• Chronic rhinosinusitis with nasal polyps
• Eosinophilic esophagitis

It is also prescribed off-label for conditions such as:

• Alopecia
• Chronic pruritus
• Lichen planus
• Localized scleroderma

People with atopic dermatitis often cycle between periods of improvement and worsening flare-ups. Dupixent is frequently prescribed when topical treatments have not provided adequate relief.

Dupixent works by blocking specific proteins in the immune system that are responsible for driving inflammation. For many patients, the medication offered meaningful relief where other therapies had not. But peer-reviewed research has raised serious concerns.

According to researchers, the same immune-altering mechanism that makes Dupixent effective may also contribute to the development or progression of cutaneous T-cell lymphoma in certain patients.

The Connection Between Dupixent and Cutaneous T-Cell Lymphoma

The scientific evidence linking dupilumab to CTCL has grown substantially in recent years. Key findings from the medical literature include:

• A 2024 study (Hasan et al.): Patients with atopic dermatitis treated with dupilumab had more than a 300% higher risk of developing CTCL compared to those who did not use the drug.
• A second 2024 study (Mandel et al.): After controlling for age, race, and sex, dupilumab-treated patients showed a 350% higher risk of CTCL diagnosis.
• A June 2025 study (Ma et al., European Respiratory Journal): Among asthma patients specifically, those using Dupixent had more than 4.5 times the risk of CTCL compared to patients on standard therapy. For patients who used the drug for 16 weeks or longer, the risk of certain T-cell and NK-cell lymphomas was significantly higher.

In its fourth-quarter 2024 quarterly FAERS report, published March 31, 2025, the U.S. Food & Drug Administration identified CTCL as a potential safety signal associated with Dupixent and is evaluating whether regulatory action is needed.

Researchers and clinicians have also documented cases in which Dupixent appeared to mask the signs of an underlying, undiagnosed lymphoma. This concerning outcome allowed the cancer to advance while patients continued treatment with Dupixent, believing their symptoms were simply eczema flare-ups instead of an aggressive form of cancer.

The Warning Signs of CTCL You Should Not Overlook

CTCL can closely resemble eczema and other inflammatory skin conditions. As a result, many patients do not realize what they are experiencing until the disease has already progressed.

If you were taking Dupixent and developed any of the following symptoms, it’s worth seeking professional guidance. Talk to your doctor about being evaluated for CTCL, and consider speaking with Attorney Dena Young about any potential claim for compensation.

Symptoms of cutaneous T-cell lymphoma include:

• Red, scaly, or thickened skin patches that do not respond to treatment as expected
• Flat or raised plaques that may be itchy or painful
• Tumors or nodules on the skin that grow or change over time
• Widespread redness covering large areas of the body
• Swollen lymph nodes in the neck, armpits, or groin
• Unexplained weight loss, night sweats, or persistent fever
• Fatigue that worsens without a clear cause

If your skin condition changed in character, worsened, or stopped responding to Dupixent rather than improving as expected, that may not have been a simple treatment failure. In some cases, this could reflect an early, unrecognized sign of lymphoma.

At Spotlight Justice, connecting those dots is part of what we do. We stand with the injured, helping our clients heal, find closure, and feel heard when they’re facing a cancer battle linked to a dangerous medication.

CTCL Diagnoses That May Qualify You for a Dupixent Lawsuit

Cutaneous T-cell lymphoma is not a single diagnosis. It encompasses a range of related blood cancers that primarily affect the skin and immune system.

If you or a loved one received any of the following diagnoses after using Dupixent, you may have grounds for a Dupixent CTCL lawsuit:

• T-cell lymphoma
• Cutaneous lymphoma
• Mycosis fungoides
• Sézary syndrome
• Peripheral T-cell lymphoma
• Subcutaneous panniculitis-like T-cell lymphoma
• Anaplastic large cell lymphoma
• Null cell types
• Extranodal natural killer/T-cell lymphoma (NK/T-cell)
• Cutaneous gamma/delta T-cell lymphoma
• Epidermotropic cytotoxic T-cell lymphoma
• Angioimmunoblastic T-cell lymphoma
• Adult T-cell lymphoma/leukemia
• Composite lymphoma
• Lymphomatoid papulosis
• Natural killer (NK)-cell lymphoblastic lymphoma

If your diagnosis does not appear on this list but you believe it may be connected to your Dupixent use, please reach out. A Dupixent CTCL lawyer will personally review your medical history and let you know whether your case may qualify.

What Dupixent Lawsuits Allege Against Sanofi and Regeneron

Dupixent lymphoma litigation centers on allegations that Sanofi and Regeneron were aware of the risk of CTCL associated with their drug and failed to adequately disclose it to patients or prescribing physicians. These ongoing lawsuits raise the following core allegations:

• Failure to warn: The CTCL risk is not reflected in Dupixent's current warning label, despite years of mounting scientific evidence and FDA safety communications raising concern about the connection.
• Misleading marketing: Manufacturers promoted Dupixent as safe and effective while downplaying or ignoring emerging safety signals suggesting a cancer risk.
• Inadequate post-market surveillance: Sanofi and Regeneron allegedly failed to conduct the ongoing safety monitoring that would have identified the CTCL risk more quickly and prompted earlier warnings to patients and physicians.
• Delayed diagnosis harm: Because CTCL can mimic eczema in its early stages, the absence of any warning prevented patients and physicians from considering lymphoma as a possible diagnosis, allowing the cancer to advance untreated in some patients.

As of February 2026, attorneys filed a motion with the Judicial Panel on Multidistrict Litigation to centralize all related Dupixent cases in the Northern District of Georgia. These are individual lawsuits, not a class action, and each client's case is evaluated and compensated based on their own medical history, injuries, and circumstances. A Dupixent lymphoma attorney can help you understand where this litigation currently stands and what filing now may mean for your case.

Compensation You May Be Able to Receive Through a Dupixent Claim

A CTCL diagnosis carries consequences that reach far beyond the doctor's office. A cancer diagnosis can impact your ability to work, your finances, your relationships, and your daily quality of life.

A successful Dupixent lawsuit can pursue compensation for a wide range of damages related to that harm. Recoverable damages may include:

• Your past and future medical costs, including cancer treatment, hospitalization, and long-term care
• Your lost income during treatment and any diminished future earning capacity
• Your physical pain and suffering due to the cancer itself and treatment side effects
• Your emotional distress and loss of quality of life
• Wrongful death damages, for bereaved families

Every case is different, and no specific outcome can be promised. But you deserve to know what may be available to you. That conversation begins with a free, confidential case review with Dena Young, a Dupixent CTCL lawyer who will give you an honest assessment of your situation.

A Dupixent Lymphoma Attorney Who Puts You First

Most large mass tort firms take on cases by the hundreds. Clients are screened, filed, and managed, often by staff members who have never spoken directly with a lawyer. At Spotlight Justice, we built our practice around a fundamentally different model, because we believe that clients facing a cancer diagnosis deserve far more than a call center and a monthly status update.

Founding attorney Dena Young brings 15 years of legal experience to every case she takes on, with a background at some of the country's most respected catastrophic injury and class action firms. She served on the Bellwether Committee for the Philips CPAP litigation, representing hundreds of clients in a case that reached a $1.1 billion settlement in 2024, and was one of the first attorneys in the country to take on cases for victims of Allergan breast implant lymphoma. She brings extensive experience building cases around medical injuries and complex scientific evidence to every Dupixent CTCL case.

At Spotlight Justice, you won’t find the impersonal machinery of a high-volume firm that churns out cases with minimal handling and no personal support. We intentionally limit our caseload so that you work directly with Dena, not a case manager, a rotating team of junior staff members, or a system that’s designed to process you. When you hire us, you receive meaningful personal attention from a Dupixent CTCL lawyer throughout our case. That consistency matters in Dupixent lymphoma cases, where building a strong claim requires careful, individualized attention to your medical history, your timeline, and your story.

We also understand that a cancer case is not just a legal matter. It is a life-altering experience that touches your health, your family, your finances, and your sense of what comes next. Dena will travel to meet you where you are, at home, in the hospital, wherever you need, because clients dealing with a serious illness should not have to come to us. Dena brings the personal attention of a boutique firm together with national mass tort credentials and a strong background in complex litigation.

Take the First Step With a Free Consultation, and Find Out What Our Firm Can Do for You

If you or a loved one developed cutaneous T-cell lymphoma after using Dupixent, the most important thing you can do right now is understand your options before time runs out. In both Pennsylvania and New Jersey, laws called statutes of limitations set strict deadlines for filing personal injury and wrongful death claims. Waiting to act can affect your right to seek compensation.

Spotlight Justice is currently reviewing Dupixent CTCL cases for clients nationwide. As your Dupixent CTCL lawyer, Dena Young will personally review your case, answer your questions honestly, and help you understand the path that may be right for you.

There are no upfront costs, no pressure, and no obligation of any kind when you consult with Spotlight Justice. We handle Dupixent lymphoma claims on a contingency fee basis, which means you pay nothing unless we secure compensation for you.

Your story deserves to be heard. Reach out to Spotlight Justice today by phone or through our online contact form to schedule your free consultation with a Dupixent lymphoma attorney who is ready to listen.